164 related articles for article (PubMed ID: 15194764)
1. The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replication.
van Opijnen T; Kamoschinski J; Jeeninga RE; Berkhout B
J Virol; 2004 Jul; 78(13):6883-90. PubMed ID: 15194764
[TBL] [Abstract][Full Text] [Related]
2. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
[TBL] [Abstract][Full Text] [Related]
3. Analysis of factors influencing kinetics of herpes simplex virus transcription utilizing recombinant virus.
Wagner EK; Petroski MD; Pande NT; Lieu PT; Rice M
Methods; 1998 Sep; 16(1):105-16. PubMed ID: 9774520
[TBL] [Abstract][Full Text] [Related]
4. The most frequent naturally occurring length polymorphism in the HIV-1 LTR has little effect on proviral transcription and viral replication.
Hiebenthal-Millow K; Kirchhoff F
Virology; 2002 Jan; 292(1):169-75. PubMed ID: 11878920
[TBL] [Abstract][Full Text] [Related]
5. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
Zhao C; Chen Y; Park J; Kim JB; Tang H
Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
[TBL] [Abstract][Full Text] [Related]
6. Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription.
Liang C; Li X; Quan Y; Laughrea M; Kleiman L; Hiscott J; Wainberg MA
J Mol Biol; 1997 Sep; 272(2):167-77. PubMed ID: 9299345
[TBL] [Abstract][Full Text] [Related]
7. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
[TBL] [Abstract][Full Text] [Related]
8. Specific sequence configurations of HIV-1 LTR G/C box array result in altered recruitment of Sp isoforms and correlate with disease progression.
Nonnemacher MR; Irish BP; Liu Y; Mauger D; Wigdahl B
J Neuroimmunol; 2004 Dec; 157(1-2):39-47. PubMed ID: 15579278
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the HIV-1 LTR as a promoter of negative sense transcription.
Bentley K; Deacon N; Sonza S; Zeichner S; Churchill M
Arch Virol; 2004 Dec; 149(12):2277-94. PubMed ID: 15338321
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.
Liu Y; Nonnemacher MR; Stauff DL; Li L; Banerjee A; Irish B; Kilareski E; Rajagopalan N; Suchitra JB; Khan ZK; Ranga U; Wigdahl B
Biomed Pharmacother; 2010 Dec; 64(10):672-80. PubMed ID: 20970301
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of human immunodeficiency virus type 2 and simian immunodeficiency virus promoter activity.
Hiebenthal-Millow K; Pöhlmann S; Münch J; Kirchhoff F
Virology; 2004 Jul; 324(2):501-9. PubMed ID: 15207635
[TBL] [Abstract][Full Text] [Related]
12. The CD8 antiviral factor (CAF) can suppress HIV-1 transcription from the long terminal repeat (LTR) promoter in the absence of elements upstream of the CATATAA box.
Shridhar V; Chen Y; Gupta P
Virol J; 2014 Jul; 11():130. PubMed ID: 25048949
[TBL] [Abstract][Full Text] [Related]
13. TATA box occupancy in the SV40 transcription elongation complex.
Kulaeva OI; Lutter LC
Virology; 2001 Jun; 285(1):119-27. PubMed ID: 11414812
[TBL] [Abstract][Full Text] [Related]
14. Recombinant and native Plasmodium falciparum TATA-binding-protein binds to a specific TATA box element in promoter regions.
Ruvalcaba-Salazar OK; del Carmen Ramírez-Estudillo M; Montiel-Condado D; Recillas-Targa F; Vargas M; Hernández-Rivas R
Mol Biochem Parasitol; 2005 Apr; 140(2):183-96. PubMed ID: 15760658
[TBL] [Abstract][Full Text] [Related]
15. Effects of multiple mutations at the conserved TATA sequence of bacteriophage SP6 promoter on transcription efficiency.
Kim SS; Hong Y; Kang C
Biochem Mol Biol Int; 1993 Sep; 31(1):153-9. PubMed ID: 8260939
[TBL] [Abstract][Full Text] [Related]
16. [The function of T7 promoter as cis-acting elements for polymerase II in eukaryotic cell].
Li YQ; Zhu JM; Li HJ; Xie WB; Zhou TH; Wang TG
Yi Chuan Xue Bao; 2000; 27(5):455-61. PubMed ID: 10979193
[TBL] [Abstract][Full Text] [Related]
17. Anti-termination by SIV Tat requires flexibility of the nascent TAR structure.
Sommer P; Vartanian JP; Wachsmuth M; Henry M; Guetard D; Wain-Hobson S
J Mol Biol; 2004 Nov; 344(1):11-28. PubMed ID: 15504399
[TBL] [Abstract][Full Text] [Related]
18. The role of the transcription bubble and TFIIB in promoter clearance by RNA polymerase II.
Pal M; Ponticelli AS; Luse DS
Mol Cell; 2005 Jul; 19(1):101-10. PubMed ID: 15989968
[TBL] [Abstract][Full Text] [Related]
19. Spacing requirements for simultaneous recognition of the adenovirus major late promoter TATAAAAG box and initiator element.
Ren D; Nedialkov YA; Li F; Xu D; Reimers S; Finkelstein A; Burton ZF
Arch Biochem Biophys; 2005 Mar; 435(2):347-62. PubMed ID: 15708378
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ; Liu X; He J
Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
